MI
EFTRW

MMCAP International’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

MMCAP International’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-145,941
Closed -$175 – 212
2024
Q2 		$175 Hold
145,941
– – ﹤0.01% 180
2024
Q1 		$19.7K Hold
145,941
– – ﹤0.01% 116
2023
Q4 		$21.5K Hold
145,941
– – ﹤0.01% 94
2023
Q3 		$11.1K Hold
145,941
– – ﹤0.01% 136
2023
Q2 		$25.3K Hold
145,941
– – 0.01% 111
2023
Q1 		$18.9K Hold
145,941
– – ﹤0.01% 190
2022
Q4 		$23.9K Hold
145,941
– – ﹤0.01% 263
2022
Q3 		$30K Hold
145,941
– – ﹤0.01% 333
2022
Q2 		$36K Hold
145,941
– – ﹤0.01% 350
2022
Q1 		$63K Hold
145,941
– – ﹤0.01% 413
2021
Q4 		$128K Sell
145,941
-4,926
-3% -$6.19K 0.01% 373
2021
Q3 		$241K Hold
150,867
– – 0.02% 303
2021
Q2 		$151 Hold
150,867
– – 0.01% 321
2021
Q1 		$92K Buy
+150,867
New +$146K 0.01% 295

MMCAP International's EFTRW Position: Q3 2024 in Review

MMCAP International sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 145,941 shares — an estimated $175 sold.

MMCAP International first reported a position in EFTRW in Q1 2021 and held it in 14 quarters. The position peaked at $241K in Q3 2021. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

  • MMCAP International reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
  • MMCAP International sold 145,941 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024, an estimated $175.
  • MMCAP International first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q1 2021 and held it in 14 quarters.
  • MMCAP International's eFFECTOR Therapeutics, Inc. Warrant position peaked at $241K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on MMCAP International's 13F filing for Q3 2024, filed 12 Nov 2024.